SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001532155-22-000055
Filing Date
2022-02-14
Accepted
2022-02-14 16:02:48
Documents
1

Document Format Files

Seq Description Document Type Size
1 Bioxcel.htm SC 13G 16484
  Complete submission text file 0001532155-22-000055.txt   18095
Mailing Address 1345 AVENUE OF THE AMERICAS NEW YORK NY 10105
Business Address 1345 AVENUE OF THE AMERICAS NEW YORK NY 10105 2129691000
ALLIANCEBERNSTEIN L.P. (Filed by) CIK: 0001109448 (see all company filings)

IRS No.: 134064930 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G
SIC: 6282 Investment Advice

Mailing Address 555 LONG WHARF DRIVE NEW HAVEN CT 06511
Business Address 555 LONG WHARF DRIVE NEW HAVEN CT 06511 203-643-8060
BioXcel Therapeutics, Inc. (Subject) CIK: 0001720893 (see all company filings)

IRS No.: 821386754 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-90437 | Film No.: 22631208
SIC: 2834 Pharmaceutical Preparations